| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/30/2009 | CA2307111C Novel pyridazine derivatives and drugs containing the same as the active ingredient |
| 06/30/2009 | CA2203480C Interferon conjugates |
| 06/30/2009 | CA2161445C Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 06/30/2009 | CA2143486C Method of improving the immune response |
| 06/30/2009 | CA2133106C Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon |
| 06/30/2009 | CA2095521C Hepatitis c virus asialoglycoproteins |
| 06/25/2009 | WO2009078983A1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/25/2009 | WO2009078802A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | WO2009078798A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | WO2009078796A1 Compositions and methods for treatment of autoimmune and allergic diseases |
| 06/25/2009 | WO2009077608A1 2 -aminopyrimidine derivatives as histamine h4 antagonists |
| 06/25/2009 | WO2009077483A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | WO2009077352A1 Prevention of opportunistic infections in immune-compromised subjects |
| 06/25/2009 | WO2009076778A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/25/2009 | WO2009076775A1 Immune response modulation and uses thereof |
| 06/25/2009 | WO2009046875A3 Combination of splenopentin and thymopentin and the use thereof in medicine |
| 06/25/2009 | WO2009046863A3 Use of thymosin alpha 1 peptide or the combination with the human pancreatic polypeptide as a therapeutic agent |
| 06/25/2009 | WO2009040046A3 Use of stresscopin-related peptide as a therapeutic agent |
| 06/25/2009 | WO2009040021A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | WO2009033746A3 Use of a peptide as a therapeutic agent |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163591 Use of sugar phosphates, sugar phosphate analogs, amino acids and/or amino acid analogs for modulating the glucolysis-enzyme complex, the malate asparate shuttle and/or the transaminases |
| 06/25/2009 | US20090163581 Pharmaceutical Products for Treating Neoplastic Disease and Inflammation |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
| 06/25/2009 | US20090163491 selective antagonists of A2B adenosine receptors; 6-Chloro-N-[5-(1-cyclopropyl-2,6-dioxo-3-propyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-pyridin-2-yl]-N-(2-pyridin-2-yl-ethyl)-nicotinamide; for treating asthma, diarrhea, insulin resistance, and diabetic retinopathy |
| 06/25/2009 | US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 06/25/2009 | US20090163469 Organic Compounds |
| 06/25/2009 | US20090163468 Fused Bicyclic mTor Inhibitors |
| 06/25/2009 | US20090163467 New compounds |
| 06/25/2009 | US20090163463 Organic Compounds |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090162935 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 06/25/2009 | US20090162427 Vaccines using nucleic acid-lipid complexes |
| 06/25/2009 | US20090162402 Immunizing compositions and methods of use |
| 06/25/2009 | US20090162400 Compositions of influenza viral proteins and methods of use thereof |
| 06/25/2009 | US20090162398 Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
| 06/25/2009 | US20090162386 Chondrocyte therapeutic delivery system |
| 06/25/2009 | US20090162377 Immunoglobulins comprising predominantly a Gal2GlcNAc2Man3GlcNAc2 glycoform |
| 06/25/2009 | US20090162374 Specific removal of activated immune cells |
| 06/25/2009 | US20090162370 Compositions and methods for conditioning a subject for hematopoietic cell transplantation |
| 06/25/2009 | US20090162366 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 06/25/2009 | US20090162348 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/25/2009 | US20090162347 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/25/2009 | US20090162342 Therapeutic uses of glandular kallikrein |
| 06/25/2009 | US20090162325 Cell implantation to prevent and/or treat autoimmune disease |
| 06/25/2009 | US20090162321 Methods for packaging propagation-defective vesicular stomatitis virus vectors using a stable cell line that expresses g protein |
| 06/25/2009 | US20090162315 Enterotoxin gene cluster (egc) superantigens to treat malignant disease |
| 06/25/2009 | US20090162292 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 06/25/2009 | US20090162279 Oligonucleotide or Its Functional Homologue, a Composition Comprising the Same and a Method of Treating B Cell Neoplasm |
| 06/25/2009 | CA2709396A1 Prevention of opportunistic infections in immune-compromised subjects |
| 06/25/2009 | CA2709266A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | CA2708854A1 Antibodies against human nkg2d and uses thereof |
| 06/25/2009 | CA2707513A1 Tetrahydrocyclopenta[b]indol-3-yl carboxylic acid derivatives useful in the treatment of autoimmune and inflammatory disorders |
| 06/25/2009 | CA2707235A1 Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin |
| 06/24/2009 | EP2072510A1 Crystalline form of azelastine |
| 06/24/2009 | EP2072052A1 Prevention of opportunistic infections in immune-compromised subjects |
| 06/24/2009 | EP2072051A1 Combination of azelastine and mometasone |
| 06/24/2009 | EP2072048A1 Use of pinolenic acid for the treatment of obesity |
| 06/24/2009 | EP2072045A2 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1590360A4 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 06/24/2009 | EP1451333B1 Ul16 binding protein 4 |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1224861B1 Test method relating to adipose cells and to obesity by using a human h-pgds overexpressing non-human animal |
| 06/24/2009 | CN100503639C Recombinant tumor specific antibody and use thereof |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100502911C An anti-rheumatism medicament and preparation method thereof |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502883C Cornel extract oral medicine compositions of low irritation to gastrointestinal tract and its preparation |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/23/2009 | US7550577 Regulation of expression of high-affinity immunoglobulin E (IgE) receptor β-chain |
| 06/23/2009 | US7550562 Having pathogenic activity that can induce pemphigus lesion; a peptide specifically recognized by the monoclonal antibody and useful as a therapeutic drug for pemphigus autoimmune disease; drug screening |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550473 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550159 For treatment of cancer and autoimmune diseases; kits |
| 06/23/2009 | US7550145 Adjuvant compositions |
| 06/23/2009 | US7550142 Anti-integrin antibodies, compositions, methods and uses |
| 06/23/2009 | US7550140 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2337494C Herpes virus vectors for dendritic cells |
| 06/18/2009 | WO2009076602A1 5-alkyl/alkenyl-3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076571A1 Indole-substituted 3-cyanopyridines as kinase inhibitors |
| 06/18/2009 | WO2009076512A1 Carboxamidξ compounds and their use as chemokine receptor agonists |
| 06/18/2009 | WO2009076404A1 Carboxamide compounds and their use as antagonists of the chemokine ccr2 receptor |
| 06/18/2009 | WO2009075854A2 Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods |
| 06/18/2009 | WO2009075826A1 Methods for increasing white blood cells |
| 06/18/2009 | WO2009075822A1 Methods for inhibiting t helper cell differentiation |